Wild Health Summit: The race to value-based care: Australia v New Zealand

2 minute read

In this video panellists discuss how hard it will be for the trans-Tasman siblings to drive digital transformation in healthcare.

Boston Consulting Group recently identified five levers to drive success and realise emerging value in Australia and New Zealand healthcare over the coming years.

They are:

  • Use digital tools to integrate fragmented delivery;
  • Unlock digitally enabled health surveillance and prevention;
  • Liberate the value of data;
  • Drive for scalability and patient experience; and
  • Build on strong relationships.

With such fragmented, outdated technology and policy that doesn’t enable the funding of new models of care at scale, the reality is this will be very hard to achieve for many years to come.

This panel explores how hard it will be for both Australia and New Zealand to drive the digital transformation required to deliver value-based care, and the foundations both countries have in place to start this journey.

New Zealand has released the Hira strategy, which offers the promise and hope of better health outcomes for all New Zealanders. The purpose of Hira is to enable people and their health providers to have better access to their health information. Hira’s vision is to connect consumers and the health workforce through multiple IT solutions such as a patient portal, enabling communications and information access in real time. Its vision is to improve communication and collaboration, leveraging off a strong foundation in linked data.

Australia too is embarking on the modernisation of its My Health Record with a sharing-by-default strategy to begin Australia’s roadmap to interoperability. Policy is starting to push providers to new models of multi-disciplinary care with MyMedicare and co-commissioning between state and federal health departments supporting new models of care.

So which country is best placed to leverage the value of these digital health strategies for their population?

In this 42-minute discussion, the panellists are:

  • Dr Penny Andrew, director of i3;
  • Kate Ebrill, the interoperability lead of the Australian e-Health Research Centre at the CSIRO;
  • Derek Felton, CEO of Felton Consulting;
  • Ryl Jensen, CEO of the Digital Health Association NZ;
  • Dr Natalie Thorne, scientific director of Genomical; and
  • Moderator Jay Rebbeck, CEO of Rebbeck.

End of content

No more pages to load

Log In Register ×